StockData
InspireMD, Inc. logo

InspireMD, Inc. (NSPR) stock

NSPRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/3054% below fair value
$0.65+0.05 (+8.33%)

Close on Nov 17, 2026Market cap $30.22MP/E –Yield –

InspireMD operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

InspireMD's operating cash flow for the twelve months ending Jun 30, 2026 was -$41.21M. For fiscal 2025 it was -$35.10M. The highest annual figure on record is -$1.55M in fiscal 2009.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$35.10M–
FY2024Dec 31, 2024-$21.87M–
FY2023Dec 31, 2023-$16.38M–
FY2022Dec 31, 2022-$15.54M–
FY2021Dec 31, 2021-$13.21M–
FY2020Dec 31, 2020-$9.08M–
FY2019Dec 31, 2019-$9.81M–
FY2018Dec 31, 2018-$7.61M–
FY2017Dec 31, 2017-$8.13M–
FY2016Dec 31, 2016-$7.50M–
FY2015Dec 31, 2015-$11.60M–
FY2013Jun 30, 2013-$10.30M–
FY2010Dec 31, 2010-$2.71M–
FY2009Dec 31, 2009-$1.55M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$10.90M–
Q1 FY2026Mar 31, 2026-$12.34M–
Q4 FY2025Dec 31, 2025-$9.35M–
Q3 FY2025Sep 30, 2025-$8.63M–
Q2 FY2025Jun 30, 2025-$8.33M–
Q1 FY2025Mar 31, 2025-$8.79M–
Q4 FY2024Dec 31, 2024-$6.75M–
Q3 FY2024Sep 30, 2024-$5.70M–
Q2 FY2024Jun 30, 2024-$4.35M–
Q1 FY2024Mar 31, 2024-$5.06M–
Q4 FY2023Dec 31, 2023-$4.18M–
Q3 FY2023Sep 30, 2023-$4.04M–
Q2 FY2023Jun 30, 2023-$3.33M–
Q1 FY2023Mar 31, 2023-$4.83M–
Q4 FY2022Dec 31, 2022-$3.20M–
Q3 FY2022Sep 30, 2022-$5.10M–
Q2 FY2022Jun 30, 2022-$3.11M–
Q1 FY2022Mar 31, 2022-$4.13M–
Q4 FY2021Dec 31, 2021-$2.90M–
Q3 FY2021Sep 30, 2021-$4.14M–
Q2 FY2021Jun 30, 2021-$2.53M–
Q1 FY2021Mar 31, 2021-$3.64M–
Q4 FY2020Dec 31, 2020-$2.20M–
Q3 FY2020Sep 30, 2020-$3.04M–
Q2 FY2020Jun 30, 2020-$1.48M–
Q1 FY2020Mar 31, 2020-$2.35M–
Q4 FY2019Dec 31, 2019-$1.57M–
Q3 FY2019Sep 30, 2019-$1.86M–
Q2 FY2019Jun 30, 2019-$2.90M–
Q1 FY2019Mar 31, 2019-$3.49M–
Q4 FY2018Dec 31, 2018-$1.80M–
Q3 FY2018Sep 30, 2018-$1.83M–
Q2 FY2018Jun 30, 2018-$2.19M–
Q1 FY2018Mar 31, 2018-$1.78M–
Q4 FY2017Dec 31, 2017-$1.78M–
Q3 FY2017Sep 30, 2017-$2.01M–
Q2 FY2017Jun 30, 2017-$1.59M–
Q1 FY2017Mar 31, 2017-$2.76M–
Q4 FY2016Dec 31, 2016-$1.88M–
Q3 FY2016Sep 30, 2016-$2.96M–

More InspireMD figures

See a number that looks wrong?